Monogram Orthopaedics Inc...
(MGRM)
undefined
undefined%
At close: undefined
2.66
-1.20%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants.
The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017.
The company was incorporated in 2016 and is headquartered in Austin, Texas.
Monogram Orthopaedics Inc.
Country | United States |
IPO Date | May 18, 2023 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 28 |
CEO | Benjamin Sexson C.F.A. |
Contact Details
Address: 3913 Todd Lane Austin, Texas United States | |
Website | https://www.monogramorthopedics.com |
Stock Details
Ticker Symbol | MGRM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001769759 |
CUSIP Number | 609786108 |
ISIN Number | US6097861081 |
Employer ID | 81-2349540 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Benjamin Sexson C.F.A. | Chairman of the Board, President & Chief Executive Officer |
Dr. Kamran Shamaei Ph.D. | Chief Technology Officer |
Noel Knape C.P.A., M.B.A. | Chief Financial Officer |
Chris Tyson | Executive Vice President - MZ North America |
Dr. Douglas Unis | Founder, Chief Medical Officer & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 02, 2024 | 8-K | Current Report |
Nov 26, 2024 | 4 | Filing |
Nov 14, 2024 | 10-Q | Quarterly Report |
Nov 14, 2024 | 8-K | Current Report |
Nov 08, 2024 | DEF 14A | Filing |
Oct 30, 2024 | PRE 14A | Filing |
Oct 29, 2024 | 8-K | Current Report |
Oct 03, 2024 | 8-K | Current Report |
Oct 02, 2024 | 424B5 | Filing |
Oct 02, 2024 | 8-K | Current Report |